Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT03729063
Other study ID # RECHMPL18_0078
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date November 19, 2018
Est. completion date June 29, 2020

Study information

Verified date December 2020
Source University Hospital, Montpellier
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The main objective of this study is to show that the repeated (twice-daily) measurement of expired CO during hospitalization helps reduce smoking.


Description:

Smoking in France represents 25 billion euros per year in care, hospitalizations and drugs and 78000 deaths / year are linked to a pathology attributable to this addiction. In addition, active consumption of cigarettes is a destabilizing factor for chronic respiratory diseases. During hospitalization for acute respiratory illness, evaluation of smoking cessation remains declarative. Although stopping advice and possibly nicotine replacement therapy are prescribed, no objective measure of smoking is performed to assess the adequacy of this attitude. This project aims to objectively evaluate smoking during hospitalization by measuring twice daily exhaled CO. The impact of this intervention on the duration of hospitalization and smoking 3m after initial admission will also be evaluated. Tobacco consumption patterns based on reason for hospital admission and background pathology will be highlighted. Secondary objectives include: - To measure the impact of expired CO measurement during hospitalization on the smoking status 1 month and 3 months after initial admission. - To determine smoking patterns during hospitalization according to reason for admission and background pathology. - To measure the effect of iterative CO measurement on the duration of stays. - To measure and compare the quality of life of patients. - To study the variability of expired CO measurements.


Recruitment information / eligibility

Status Terminated
Enrollment 67
Est. completion date June 29, 2020
Est. primary completion date December 16, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patient hospitalized in pneumology for acute respiratory illness or scheduled hospitalization, for a minimum duration of 48h. - Signature of informed consent - Patient able to perform all visits and follow the procedures of the study - Affiliatedor beneficiary of French social security (national health insurance) Exclusion Criteria: - Subject who can not read and / or write French - Expected travel that precludes study completion - Patient in palliative care - Inability to maintain apnea more than 8 seconds - Participation in another clinical trial or administration of an off-label drug within 4 weeks prior to inclusion

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Twice-daily expired carbon monoxide (CO) measurements
Patients included in this arm will have expired CO measurements every morning and evening during their initial hospitalization.
Minimal control
Patients included in this arm will have one expired CO measurement on the morning just after initial hospital admission and a second expired CO measurement one the morning prior to discharge.

Locations

Country Name City State
France Hôpital Arnaud de Villeneuve - CHU de Montpellier Montpellier

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Montpellier

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary % variation in expired CO Baseline to hospital discharge (expected maximum of 28 days)
Secondary Length of hospital stays Admission and discharge dates are recorded throughout 3 months of follow-up 3 months
Secondary Smoking status (never, former current) Baseline (day 0)
Secondary Smoking status (never, former current) 1 month
Secondary Smoking status (never, former current) 3 months
See also
  Status Clinical Trial Phase
Completed NCT03999411 - Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients Phase 4
Completed NCT03931772 - Online Automated Self-Hypnosis Program N/A
Completed NCT02649556 - A 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2 N/A
Completed NCT03901066 - Smoking Dependence and Periodontitis
Recruiting NCT05846841 - Personalized Tobacco Treatment in Primary Care (MOTIVATE) N/A
Completed NCT03170752 - Implementing and Testing a Cardiovascular Assessment Screening Program (CASP) N/A
Completed NCT03305978 - Pulmonary Nodule Detection: Comparison of an Ultra Low Dose vs Standard Scan. N/A
Completed NCT00000437 - Tobacco Dependence in Alcoholism Treatment (Nicotine Patch/Naltrexone) Phase 4
Completed NCT06105424 - BRP1602: Evaluation of Technical and Logistical Feasibility to Measure Lung Permeability N/A
Active, not recruiting NCT02752022 - Monitoring the Transition From Smoking to E-cigarettes
Completed NCT02912000 - TEACH: Technology Evaluation to Address Child Health N/A
Completed NCT02901171 - The Contribution of a Smartphone Application to Acceptance and Commitment Therapy Group Treatment for Smoking Cessation N/A
Completed NCT03206619 - A Health Recommeder System to Tailor Message Preferences in a Smoking Cessation Programme
Completed NCT04340830 - The Effect of Smoking on Dimensional Changes of Free Gingival Graft Around Dental Implants N/A
Completed NCT02949648 - Electronic Cigarette Use and Quitting in Youth N/A
Completed NCT02945371 - Tailored Inhibitory Control Training to Reverse EA-linked Deficits in Mid-life N/A
Completed NCT02246114 - Self-Monitoring of Carbon Monoxide to Enhance Reproductive Outcomes in Women N/A
Completed NCT01898507 - Nicotine Metabolism and Low Nicotine Cigarettes N/A
Completed NCT02008292 - Acetylcholine, Tobacco Smoking, Genes and Nicotinic Receptors N/A
Completed NCT01954407 - Young Adults' Responses to Anti-smoking Messages N/A